Connect Biopharma Holdings Limited
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CNTB Key Statistics
Stock Snapshot
As of today, Connect Biopharma Holdings Limited(CNTB) shares are valued at $2.73. The company's market cap stands at 152.34M, with a P/E ratio of -9.51.
During the trading session on 2025-12-29, Connect Biopharma Holdings Limited(CNTB) shares reached a daily high of $2.75 and a low of $2.43. At a current price of $2.73, the stock is +12.2% higher than the low and still -0.9% under the high.
Trading volume for Connect Biopharma Holdings Limited(CNTB) stock has reached 71.39K, versus its average volume of 138.16K.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
CNTB News
Claim 70% Off TipRanks This Holiday Season Connect Biopharma Holdings ( (CNTB) ) has provided an update. On December 17, 2025, Connect Biopharma Holdings anno...